Ceres (NASDAQ: CERE) has been awarded a U.S. patent for its iCODE multi-gene trait development system. The company indicated that ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE